MEGAN E BROWN
Allopathic & Osteopathic Physicians|Family Medicine ABILENE, KS NPI 1821389180
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine KS NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$2,283.33
- Category: General Payments
- Program years: PY2018–2024
- Record count: 122
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $129.02 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $129.02 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $45.92 | 3 |
| Novo Nordisk AS | $32.34 | 2 |
| PFIZER INC. | $21.55 | 1 |
| ABBVIE INC. | $16.06 | 1 |
| Otsuka America Pharmaceutical, Inc. | $13.15 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086627037 | Novartis Pharmaceuticals Corporation | $13.89 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086627041 | Novartis Pharmaceuticals Corporation | $14.79 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086627049 | Novartis Pharmaceuticals Corporation | $17.24 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097148289 | Novo Nordisk Inc | $13.12 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097402475 | Novo Nordisk Inc | $19.22 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103378325 | ABBVIE INC. | $16.06 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118868092 | Otsuka America Pharmaceutical, Inc. | $13.15 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131278160 | PFIZER INC. | $21.55 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.